Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vicky Kritikos is active.

Publication


Featured researches published by Vicky Kritikos.


Journal of Asthma | 2005

The Validity and Reliability of Two Asthma Knowledge Questionnaires

Vicky Kritikos; Ines Krass; Hui Shen Chan; Sinthia Bosnic-Anticevich

Background. This study aimed to develop and validate two asthma knowledge questionnaires, one for consumers (CQ) and one for health care professionals (HQ) to fill an existing gap in the literature. Methods. Following development and pilot testing, the revised CQ and HQ were administered to respiratory physicians, pharmacists and people with asthma and without asthma. Results. Both the CQ and HQ were shown to be reliable with Cronbachs alpha of 0.78 and 0.92 respectively. Both were also found to have good content, face, construct and discriminant validity. Conclusion. The CQ and HQ were shown to be simple, valid and reliable instruments for the assessment of asthma knowledge of consumers and health care professionals and to direct educational resources more appropriately. Future research will evaluate the utility of these instruments in clinical practice.


Journal of Asthma | 2007

Interactive Small-Group Asthma Education in the Community Pharmacy Setting: A Pilot Study

Vicky Kritikos; Carol L. Armour; Sinthia Bosnic-Anticevich

Background. This study aimed to compare the effects of two small-group asthma education interventions (one delivered by specially trained pharmacists (group A) and one delivered by a pharmacist researcher trained as an asthma educator (group B)) with usual care provided by community pharmacists (group C) on clinical and humanistic outcomes for people with asthma. Methods. Pharmacies were randomly selected to provide either group A, B, or C interventions. Data were collected at baseline, post intervention (groups A and B) and at 6 and 12 weeks (final visit). Results. Forty-eight people with asthma were recruited into groups A (n = 16), B (n = 16), and C (n = 16) and there were no significant differences between the groups at baseline. At 12 weeks there was a significant decrease in the proportion of patients with severe asthma/poor control in groups A and B compared with group C (56%, 44% and 50% to 25%, 13% and 50% [n = 48, p < 0.05], respectively). In Groups A and B, the proportion of patients with optimal metered dose inhaler (MDI) technique improved from 9% and 14%, respectively, at baseline to 82% and 93% (n = 11, p = 0.02, n = 14, p < 0.001), respectively, at 12 weeks. The proportion of patients with optimal dry powder inhaler (DPI) technique improved in Groups A and B from 0% and 8%, respectively, at baseline to 86% and 92% (n = 7, p < 0.001; n = 13, p = 0.002), respectively, at 12 weeks. No change in inhaler technique was observed for Group C. There were significant improvements in asthma knowledge scores in Groups A and B compared to Group C over time. Conclusions. Small-group asthma education delivered by pharmacists appears to be more effective than usual care in improving clinical and humanistic asthma outcomes.


Internal Medicine Journal | 2016

Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

Peter G. Gibson; Helen K. Reddel; Vanessa M. McDonald; Guy B. Marks; Christine Jenkins; Andrew Gillman; John W. Upham; Michael Sutherland; Janet Rimmer; Frank Thien; Greg P Katsoulotos; Matthew Cook; Ian A. Yang; C Katelaris; Simon D. Bowler; David Langton; Paul Robinson; Craig Wright; Veronica Yozghatlian; Scott Burgess; Pathmanathan Sivakumaran; Adam Jaffe; Jeff Bowden; Peter Wark; Kwok Yan; Vicky Kritikos; Matthew J. Peters; Mark Hew; Ali Aminazad; Michael Bint

Severe asthma is a high impact disease. Omalizumab targets the allergic inflammatory pathway; however, effectiveness data in a population with significant comorbidities are limited.


Clinical & Experimental Allergy | 2016

Real‐life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria

Mark Hew; Andrew Gillman; Michael Sutherland; Peter Wark; Jeff Bowden; Michael Guo; Helen K. Reddel; Christine Jenkins; Guy B. Marks; Frank Thien; Janet Rimmer; Gregory P Katsoulotos; Matthew Cook; Ian A. Yang; Constance H. Katelaris; Simon D. Bowler; David Langton; Craig Wright; Michael Bint; Veronica Yozghatlian; Scott Burgess; Pathmanathan Sivakumaran; Kwok Yan; Vicky Kritikos; Matthew J. Peters; Melissa Baraket; Ali Aminazad; Paul Robinson; Adam Jaffe; Heather Powell

Omalizumab (Xolair) dosing in severe allergic asthma is based on serum IgE and bodyweight. In Australia, patients eligible for omalizumab but exceeding recommended ranges for IgE (30–1500 IU/mL) and bodyweight (30–150 kg) may still receive a ceiling dose of 750 mg/4 weeks. About 62% of patients receiving government‐subsidized omalizumab are enrolled in the Australian Xolair Registry (AXR).


International Journal of Pharmacy Practice | 2013

Undergraduate pharmacy students’ perceptions of research in general and attitudes towards pharmacy practice research

Vicky Kritikos; Steven Carter; Rebekah Moles; Ines Krass

To investigate pharmacy students’ perceptions of research in general and attitudes towards pharmacy practice research (PPR) at each stage of the undergraduate programme and determine any relationship between perceptions and attitudes, and to validate a measure of attitudes towards PPR in an Australian cohort of pharmacy students.


SpringerPlus | 2013

Smoking cessation in community pharmacy practice–a clinical information needs analysis

Maya Saba; Renee Bittoun; Vicky Kritikos; Bandana Saini

BackgroundWith the emerging role of pharmacists in implementing smoking cessation services and the recent evidence about smoking cessation pharmacotherapies, a needs analysis to assess baseline knowledge about current smoking cessation practice is needed; hence, training and development in this area can target possible ‘gaps’.ObjectiveThis study aimed at exploring pharmacy students’ knowledge about and attitudes toward smoking cessation, as compared to practicing community pharmacists and smoking cessation educators. The overall objective was to uncover underlying ‘gaps’ in pharmacy-based smoking cessation practice, particularly clinical gaps.SettingFinal-year pharmacy students at the University of Sydney, practicing community pharmacists and smoking cessation educators in Australia.MethodAs no previous standard pharmacist-focused smoking cessation knowledge questionnaires exist, a review of the literature informed the development of such a questionnaire. The questionnaire was administered to a cohort of fourth-year pharmacy students at the University of Sydney, practicing pharmacists and smoking cessation educators. Data analysis was performed using Predictive Analytics SoftWare (PASW® Statistics 18). Mean total scores, independent t-tests, analysis of variances and exploratory factor analysis were performed.Main outcome measureTo determine areas of major clinical deficits about current evidence related to smoking cessation interventions at the pharmacy level.ResultsResponses from 250 students, 51 pharmacists and 20 educators were obtained. Smoking educators scored significantly higher than pharmacists and students (P < .05), while score differences in the latter two groups were not statistically significant (P > .05). All groups scored high on ‘general’ knowledge questions as compared to specialised pharmacologic and pharmacotherapeutic questions. All respondents demonstrated positive attitudes toward the implications of smoking cessation. Factor analysis of the 24-item knowledge section extracted 12 items loading on 5 factors accounting for 53% of the total variance.ConclusionsThe results provide a valid indication of ‘gaps’ in the practice of up-to-date smoking cessation services among Australian pharmacy professionals, particularly in clinical expertise areas involving assessment of nicotine dependence and indications, dosages, adverse effects, contraindications, drug interactions and combinations of available pharmacotherapies. These gaps should be addressed, and the results should inform the design, implementation and evaluation of a pharmacy-based educational training program targeting current clinical issues in smoking cessation.


Journal of Asthma | 2018

Inhaler technique mastery and maintenance in healthcare professionals trained on different devices

Sinthia Bosnic-Anticevich; Christina Callan; Henry Chrystyn; Federico Lavorini; Vasilis Nikolaou; Vicky Kritikos; P. N. Richard Dekhuijzen; Nicolas Roche; Leif Bjermer; Cynthia Rand; Nicholas Zwar; David Price

ABSTRACT Objective: Healthcare professionals (HCPs) are required to assess and train patients in the correct use of inhalers but are often unable to demonstrate correct technique themselves. We sought to assess the level of training required for HCPs to master and maintain device mastery when using two different dry powder inhalers (DPIs). Methods: We conducted a randomized, un-blinded, crossover study in undergraduate HCPs who undertook a six-step training procedure (intuitive use, patient information leaflet, instructional video, individual tuition from expert, then two repeats of individual tuition) for the use of Turbuhaler® (an established device) and Spiromax® (a newer device, reportedly easier to use). Device mastery (absence of errors) was evaluated by expert assessors at each training step. Maintenance of mastery was assessed 4 ± 1 week (visit 2) and 8 ± 2 weeks (visit 3) after initial training (visit 1). Results: Of 516 eligible participants, 113 (22%) demonstrated device mastery prior to training on Spiromax® compared with 20 (4%) on Turbuhaler® (p < 0.001). The median number of training steps required to achieve mastery was 2 (interquartile range [IQR] 2–4) for Spiromax® and 3 (IQR 2–4) for Turbuhaler® (p < 0.001). A higher number of participants maintained mastery with Spiromax® compared with Turbuhaler®, at visits 2 and 3 (64% vs 41% and 79% vs 65%, respectively; p < 0.001). Conclusions: There are significant differences in the nature and extent of training required to achieve and maintain mastery for Spiromax® and Turbuhaler® devices. The implications on clinical practice, device education delivery, and patient outcomes require further evaluation.


Journal of Asthma | 2017

Improving childcare staff management of acute asthma exacerbation – An Australian pilot study

Yien Yien Soo; Kate Luckie; Bandana Saini; Vicky Kritikos; John D. Brannan; Rebekah Moles

ABSTRACT Objective: This study aimed to evaluate the effectiveness of an asthma first-aid training tool for childcare staff in Australia. The effects of training on both asthma knowledge and skills were assessed. Methods: A pre/post-study design was utilised to assess changes in asthma knowledge and asthma first-aid skills in childcare staff before and after an educational intervention. Asthma first-aid skills were assessed from the participants response to two scenarios in which a child was having a severe exacerbation of asthma. Asthma knowledge and asthma skills scores were collected at base-line and 3 weeks post the education session, which involved feedback on each individuals skills and a brief lecture on asthma delivered via PowerPoint presentation. Results: There was a significant improvement after intervention in asthma knowledge (Z = −3.638, p < 0.001) and asthma first-aid skills for both scenario 1 (Z = −6.012, p < 0.001) and scenario 2 (Z = −6.018, p < 0.001). In scenario 1 and 2, first-aid skills improved by 65% (p < 0.001) and 57% (p < 0.001), respectively. Asthma knowledge was high at baseline (79%) and increased by 7% (p < 0.001) after the educational intervention. These asthma knowledge results were not significant when adjusted for prior knowledge. Results suggest that knowledge assessment alone may not predict the practical skills needed for asthma first-aid. Conclusions: Skills assessment is a useful adjunct to knowledge assessment when gauging the ability of childcare staff to manage acute asthma exacerbation. Skills assessment could be considered for incorporation into future educational interventions to improve management of acute asthma exacerbation.


Pharmacy Practice (internet) | 2015

Factors influencing pharmacy students’ attitudes towards pharmacy practice research and strategies for promoting research interest in pharmacy practice

Vicky Kritikos; Bandana Saini; Stephen R. Carter; Rebekah Moles; Ines Krass

Objectives: To (1) investigate the relationships between students’ characteristics and their (a) perceptions of research in general and (b) attitudes towards pharmacy practice research; (2) identify strategies that could be used by pharmacy educators to promote research interest in pharmacy practice; and (3) identify perceived barriers to the pursuit or completion of a pharmacy practice research degree. Methods: A survey was administered to all students enrolled in each year of the four-year pharmacy undergraduate program, University of Sydney, Australia. Perceptions of research in general were measured using 4 items on a five-point semantic-differential scale and attitudes towards pharmacy practice research were measured using 16 items on a five-point Likert scale. Student characteristics were also collected as were responses to open-ended questions which were analysed using content analysis. Results: In total 853 students participated and completed the survey (83% response rate). Participants’ characteristics were associated with some but not all aspects of research and pharmacy practice research. It appeared that positive attitudes and perspectives were influenced strongly by exposure to the ‘research’ process through projects, friends or mentors, previous degrees or having future intentions to pursue a research degree. Results from both the quantitative and qualitative analyses suggest positive attitudes and perceptions of research can be nurtured through the formal inclusion in research processes, particularly the utility of practice research in clinical practice across the four years of study. Participants indicated there was a lack of awareness of the needs, benefits and career opportunities associated with pharmacy practice research and voiced clear impediments in their career path with respect to the choice of practice research-related careers. Conclusions: Future research should investigate changes in perceptions and attitudes in a single cohort over the four-year degree, other factors influencing students’ perceptions and attitudes, and evaluate the effectiveness of research promoting strategies and programs.


npj Primary Care Respiratory Medicine | 2018

Tell me about your hay fever: a qualitative investigation of allergic rhinitis management from the perspective of the patient

Biljana Cvetkovski; Vicky Kritikos; Kwok Yan; Sinthia Bosnic-Anticevich

Allergic rhinitis (AR) is sub-optimally managed in the community and is responsible for a significant health and economic burden. Uncontrolled AR increases the risk of poorly controlled asthma and presents an increased susceptibility to thunderstorm asthma. With the availability of treatments over-the-counter, bypassing the health care professional (HCP), the role of the patient is paramount. Research on the role of the patient in AR management in the current environment is limited. This study aims to explore the patient perspective of AR management and understand why it is sub-optimally managed in the community. Patient perspectives of AR management were explored utilizing a qualitative, phenomenological approach. Adults with AR were included in the study and interviewed. Transcripts were analyzed for recurrent themes and emergent concepts. Forty-seven participants with AR were interviewed about their experiences. Patient reports of delayed diagnosis, treatment fatigue and confidence in the ability to manage their AR themselves, heavily influenced their management preferences. Patients also described barriers associated with AR management including financial expense as well as being mistaken for having an infectious disease. Patients described examples of the impact on their quality of life caused by their AR, yet they strongly believed they could manage it themselves. This belief that AR is a condition that should be entirely self-managed, contributes to its burden. It amplifies patients’ separation from HCPs and having access to guidelines aimed at optimizing their AR control.Allergic rhinitis: Reaching beyond over-the-counter medicationsHealthcare professionals must engage fully with allergic rhinitis patients to optimize treatment and avoid issues triggered by constant self-care. Allergic rhinitis, or hay fever, can impact hugely on individuals’ health but remains poorly managed, partly because of the multiple medications available that allow people to bypass doctors and treat themselves. Biljana Cvetkovski at the University of Sydney, Australia, and co-workers, interviewed 47 adults with hay fever to analyze perceptions of the condition and its management. Many patients reported disenchantment with professional guidance for hay fever, often citing delayed diagnosis and endless tests leading to long-term ‘treatment fatigue’ and a loss of confidence in healthcare services. Patients often prefer self-treatment with limited medical help, repeatedly switching between medications and opting for ‘quick fixes’ rather than treating the chronic condition, with sometimes serious consequences.

Collaboration


Dive into the Vicky Kritikos's collaboration.

Top Co-Authors

Avatar

Sinthia Bosnic-Anticevich

Woolcock Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kwok Yan

Royal Prince Alfred Hospital

View shared research outputs
Top Co-Authors

Avatar

David Price

University of Aberdeen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rachel Tan

Woolcock Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge